Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study

Abstract Background β-lactams are the main antibiotics used against wild-type AmpC-producing Enterobacterales (wtAE). However, they may fail or select AmpC-overproducing mutants. Our aim was to assess factors associated with clinical failure of β-lactams in the treatment of wtAE infection. Methods F...

Descripció completa

Dades bibliogràfiques

Autors principals:	Roman Mounier, Ronan Le Guen, Paul-Louis Woerther, Mathieu Nacher, Clément Bonnefon, Nicolas Mongardon, Olivier Langeron, Eric Levesque, Séverine Couffin, Stéphanie Houcke, Michel Wolff, Ariane Roujansky, Caroline Schimpf, Armand Mekontso Dessap, Fabrice Cook, Keyvan Razazi, Hatem Kallel
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-11-01
Col·lecció:	Annals of Intensive Care
Matèries:	AmpC-producing Enterobacterales AmpC β-lactamases Third-generation cephalosporins Infection ICU
Accés en línia:	https://doi.org/10.1186/s13613-022-01079-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!